Should You Buy Oxbridge Re Holdings Limited Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Oxbridge Re Holdings Limited (OXBR) carries a solid Quality of Company rating of 6.3/10. Trading at $1.42, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 0 of 1 CirclFi valuation models project upside for Oxbridge Re Holdings Limited (OXBR) at $1.42 — the model consensus leans bearish, with a Quality Score of 6.3/10 and Value-Trap risk of 24/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Oxbridge Re Holdings Limited (OXBR) in 2026?
What Is the Bull Case vs the Bear Case for Oxbridge Re Holdings Limited (OXBR)?
| Bull case | Bear case — $0.97 target (-31.6%) |
|---|---|
| No active model projects meaningful upside for OXBR at $1.42. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. | According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model sees the stock as overvalued with a fair value of $0.97 (-31.6%), suggesting that the market price embeds overly optimistic growth assumptions. |
| Industry headwind: investment portfolio risk represents a meaningful risk for Oxbridge Re Holdings Limited and its Insurance - Reinsurance peers. |
How Does OXBR Compare to Its Insurance - Reinsurance Peers?
Valuation data pages: RNR · GLRE · HG · EG · RGA · SPNT · KG
Which Other Stocks Score Like OXBR on Quality?
Closest companies to OXBR’s Quality of Company score of 6.3/10, across all industries.
- NTLA — Intellia Therapeutics, Inc. (QOC 6.3) · analysis
- XFOR — X4 Pharmaceuticals, Inc. (QOC 6.3) · analysis
- CRDL — Cardiol Therapeutics Inc. (QOC 6.3) · analysis
- PLUR — Pluri Inc. (QOC 6.2) · analysis
- ZYBT — Zhengye Biotechnology Holding Limited (QOC 6.3) · analysis
- EVGO — EVgo, Inc. (QOC 6.2) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is Oxbridge Re Holdings Limited (OXBR) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on Oxbridge Re Holdings Limited at $1.42. 1/1 models flag overvaluation, median fair value sits at $0.97 (-31.6%), and the risk-reward profile appears unfavorable. Quality at 6.3/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Oxbridge Re Holdings Limited's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About OXBR Stock?
Should I buy OXBR stock right now?
Based on CirclFi's multi-model analysis, 0 of 1 models see upside for OXBR at $1.42. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Oxbridge Re Holdings Limited?
Key risks include: limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Insurance - Reinsurance companies. Always diversify and consult a financial advisor.
How does OXBR compare to its competitors?
Among Insurance - Reinsurance peers, OXBR holds a Quality Score of 6.3/10. Comparable companies include RNR (QOC 9.4), GLRE (QOC 9.1), HG (QOC 9.0). The relative ranking helps investors identify whether OXBR offers better fundamental quality than alternatives in the same sector.
Is OXBR a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. OXBR's Quality Score of 6.3/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy OXBR at?
CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $0.97 to $0.97. At $1.42, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for OXBR.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad